Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Safety Profile: Common Side Effects : Nausea, vomiting, and diarrhea are the most commonly reported side effects
Unlike vitamin B12 deficiency, which produces well-recognised neurological and haematological manifestations, excess B12 does not typically generate a distinct clinical syndrome
No scheduling conflict
Cagrilintide Dose Escalation Studies Phase 2 trials evaluated multiple cagrilintide doses to identify the optimal balance between efficacy and tolerability: 0.3 mg weekly Minimal efficacy, excellent tolerability 0.6 mg weekly Moderate effects, good tolerability 1.2 mg weekly Strong efficacy, acceptable side effects 2.4 mg weekly Optimal efficacy-tolerability balance 4.5 mg weekly Excessive GI side effects outweighed benefits The 2.4 mg weekly dose emerged as the standard in phase 3 trials, providing substantial metabolic benefits while maintaining an acceptable side effect profile[6]
US$ 21.22
US$ 27.32
US$ 26.69
US$ 24.88
US$ 22.81
US$ 26.09
US$ 25.17
US$ 20.59
